Pfizer: tightens up FY EPS guidance

(CercleFinance.com) - Pfizer has raised the low end of its full-year adjusted EPS guidance by five cents to 6.
30 to 6.45 dollars, confirming that it now expects revenues of 98 to 102 billion dollars.

The company reported adjusted net profit that is up 94% to nearly 11.7 billion dollars for the Q2 2022, or 2.04 dollars per share, on revenue that is up 47% to over 27.7 billion dollars (+53% in operating terms).

The pharmaceutical giant said that this growth continued to reflect its dynamic vaccines division, where revenues rose by 20%, still driven by demand for its Comirnaty vaccine developed with BioNTech against Covid-19.


Copyright (c) 2022 CercleFinance.com. All rights reserved.